Ninety One North America Inc. Has $848,000 Stock Position in CME Group Inc. $CME

Ninety One North America Inc. reduced its position in shares of CME Group Inc. (NASDAQ:CME) by 15.3% in the 2nd quarter, Holdings Channel reports. The firm owned 3,075 shares of the financial services provider’s stock after selling 557 shares during the period. Ninety One North America Inc.’s holdings in CME Group were worth $848,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Wayfinding Financial LLC bought a new stake in shares of CME Group during the first quarter worth $25,000. Webster Bank N. A. boosted its position in CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 60 shares during the last quarter. Cornerstone Planning Group LLC boosted its position in CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. Highline Wealth Partners LLC boosted its position in CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 43 shares during the last quarter. Finally, Golden State Wealth Management LLC boosted its position in CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 98 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Activity

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of the company’s stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the sale, the insider directly owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director William R. Shepard acquired 262 shares of CME Group stock in a transaction on Thursday, September 25th. The stock was purchased at an average cost of $265.19 per share, with a total value of $69,479.78. Following the completion of the transaction, the director directly owned 258,459 shares in the company, valued at $68,540,742.21. This represents a 0.10% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages have commented on CME. Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and upped their price target for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. Wall Street Zen lowered shares of CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. Piper Sandler upped their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a report on Tuesday, July 15th. Oppenheimer upped their price objective on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a report on Thursday, July 24th. Finally, Barclays set a $298.00 price objective on shares of CME Group and gave the company an “equal weight” rating in a report on Thursday, July 24th. Five research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus target price of $268.14.

CME Group Trading Down 0.8%

Shares of CME stock opened at $270.19 on Wednesday. CME Group Inc. has a 52-week low of $213.94 and a 52-week high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The company has a 50-day simple moving average of $270.73 and a two-hundred day simple moving average of $271.13. The company has a market capitalization of $97.37 billion, a price-to-earnings ratio of 26.16, a PEG ratio of 4.93 and a beta of 0.43.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the prior year, the firm posted $2.56 EPS. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. Research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s dividend payout ratio is presently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.